NM_001184.4:c.5305G>C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001184.4(ATR):c.5305G>C(p.Glu1769Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 152,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001184.4 missense
Scores
Clinical Significance
Conservation
Publications
- Seckel syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndromeInheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- Seckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial prostate carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001184.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATR | NM_001184.4 | MANE Select | c.5305G>C | p.Glu1769Gln | missense | Exon 31 of 47 | NP_001175.2 | ||
| ATR | NM_001354579.2 | c.5113G>C | p.Glu1705Gln | missense | Exon 30 of 46 | NP_001341508.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATR | ENST00000350721.9 | TSL:1 MANE Select | c.5305G>C | p.Glu1769Gln | missense | Exon 31 of 47 | ENSP00000343741.4 | ||
| ATR | ENST00000513291.2 | TSL:1 | n.489G>C | non_coding_transcript_exon | Exon 1 of 16 | ||||
| ATR | ENST00000661310.1 | c.5113G>C | p.Glu1705Gln | missense | Exon 30 of 46 | ENSP00000499589.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251456 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74348 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.5305G>C (p.E1769Q) alteration is located in exon 31 (coding exon 31) of the ATR gene. This alteration results from a G to C substitution at nucleotide position 5305, causing the glutamic acid (E) at amino acid position 1769 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome Uncertain:1
Seckel syndrome 1 Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at